Humana targets internal cuts amid Medicare Advantage challenges
Humana will look for ways to improve operating efficiency and medical cost management, incoming CEO Jim Rechtin said.
Humana will look for ways to improve operating efficiency and medical cost management, incoming CEO Jim Rechtin said.
This analysis indicates that quantitative interstitial abnormalities may indicate alterations in lung tissue processes that can result in short- and long-term consequences as far as…
AUA 2024, N-803 plus BCG, Non Muscle Invasive Bladder Cancer (NMIBC), BCG Refractory, QUILT 3032 trial, ANKTIVA, interleukin-15 superagonist (IL-15), BCG-unresponsive high-grade NMIBC.
Yale alleges Prospect hasn’t paid clinicians and vendors, let the state of its facilities decline and is in danger of losing a Medicare contract.
AUA 2024, non-muscle invasive bladder cancer (NMIBC), trans urethral resection of bladder tumor (TURBT), HG T1 bladder cancer, Replacing ReTUR with Cystoscopy, HuNIRe trial, urine cytology,…
AUA 2024 efficacy of repeat BCG challenge in patients with “BCG unresponsive” non-muscle invasive bladder cancer (NMIBC), BCG-unresponsive NMIBC,
HHS announced Friday it would publish a final rule extending Obamacare access to people under the Deferred Action for Childhood Arrivals program, or DACA.
Andrea Apolo joins Sam Chang in discussing the AMBASSADOR study, focusing on adjuvant pembrolizumab for muscle-invasive urothelial carcinoma. The study showed improved disease-free survival with…
Here is what five telehealth executives and investors had to say about Walmart and others exiting virtual care.
AUA 2024 third interim analysis of the DARolutamide ObservationaL (DAROL) study, nonmetastatic castration-resistant prostate cancer (nmCRPC), DAROL study, darolutamide, phase 3 ARAMIS trial.
AUA 2024, muscle-invasive bladder cancer (MIBC), depression in muscle-invasive bladder cancer patients, neoadjuvant chemotherapy (NAC), Effects of Neoadjuvant Chemotherapy on Rates of Depression.